Physician profile
Mamta Patel
NPI 1710923768
$6,313.30
in general payments reported to CMS, 2019-2025
15 companies · $16.86 in 2025
The $16.86 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,112 · 2020: $508 · 2021: $1,676 · 2025: $16.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $3,746.28 | 2019 | |
| Allergan, INC. | $1,436.23 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $202.62 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $186.09 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $157.75 | 2020-2021 | |
| Genentech USA, INC. | $132.62 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $95.83 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $88.53 | 2019-2021 | |
| Biotissue Holdings INC. | $66.29 | 2020-2025 | |
| Alcon Vision LLC | $64.62 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $55.28 | 2019-2021 | |
| Optos, INC. | $24.93 | 2021 | |
| Eyepoint US, INC. | $22.09 | 2019 | |
| Notal Vision, INC. | $18.94 | 2019 | |
| Rxsight INC | $15.20 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mamta Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.